Trials / Conditions / Stage III Pleural Malignant Mesothelioma AJCC v7
Stage III Pleural Malignant Mesothelioma AJCC v7
3 registered clinical trials studyying Stage III Pleural Malignant Mesothelioma AJCC v7.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patien NCT03228537 | National Cancer Institute (NCI) | Phase 1 |
| Active Not Recruiting | Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors NCT03074513 | M.D. Anderson Cancer Center | Phase 2 |
| Terminated | Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma NCT02408016 | Fred Hutchinson Cancer Center | Phase 1 / Phase 2 |